Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steady-State PK/PD of Tysabri in MS
NCT00744679Phase 4Completed
- Sponsor
- Biogen
- Start
- Nov 2008
- Primary completion
- Dec 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of natalizumab in multiple sclerosis (MS), sponsored by Biogen. Started Nov 2008; status: completed.
02
Drugs
natalizumab
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00744679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00744679.